Last Posted: Jan 30, 2023
- Innate immunity influences long-term outcomes after human lung transplant.
Palmer Scott M, et al. American journal of respiratory and critical care medicine 2005 0 (7) 780-5
- Clinical and Genetic Spectrum of Children with Primary Ciliary Dyskinesia in China.
Guan Yuhong et al. Chest 2021 Feb
- A Single Nucleotide C3 Polymorphism Associates With Clinical Outcome After Lung Transplantation.
Kardol-Hoefnagel Tineke, et al. Frontiers in immunology 2019 0 2245
- Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: The effect of NOD2/CARD15 mutations in a Tunisian population.
Touihri Mouna, et al. Human immunology 2019 3 (3) 163-168
- Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation.
Budding Kevin, et al. Frontiers in immunology 2017 0 1109
- HLA Mismatching Favoring Host-Versus-Graft NK Cell Activity Via KIR3DL1 Is Associated With Improved Outcomes Following Lung Transplantation.
Greenland John R, et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017 4
- The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
Sullivan Lucy C, et al. PloS one 2015 0 (8) e0135972
- Post-infectious bronchiolitis obliterans and mannose-binding lectin insufficiency in Argentinean children.
Giubergia Verónica, et al. Respirology (Carlton, Vic.) 2015 8 (6) 982-6
- Donor clara cell secretory protein polymorphism is a risk factor for bronchiolitis obliterans syndrome after lung transplantation.
Bourdin Arnaud, et al. Transplantation 2012 9 (6) 652-8
- A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantation.
Kastelijn Elisabeth A, et al. Fibrogenesis & tissue repair 2011 0 (1) 24
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:May 27, 2023
- Content source: